Thu, February 20, 2020

Madhu Kumar Initiated (ABUS) at Buy and Held Target at $8 on, Feb 20th, 2020

Madhu Kumar of Baird, Initiated "Arbutus Biopharma Corporation" (ABUS) at Buy and Held Target at $8 on, Feb 20th, 2020.

Madhu has made no other calls on ABUS in the last 4 months.



There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, 0 agree with Madhu's Rating of Hold.



This is the rating of the analyst that currently disagrees with Madhu


  • Liisa Bayko of "JMP Securities" Upgraded from Hold to Buy and Held Target at $10 on, Wednesday, February 5th, 2020